Ketoprofen 50 MG Oral Capsule — RxCUI 197855
RxNorm drug concept · Semantic clinical drug
RxCUI 197855
Semantic clinical drug · SCD
● Current RxNorm concept 4 FDA products
4 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI197855
Official nameKetoprofen 50 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped4
Package NDCs mapped4
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Ketoprofen: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- The main difference is how quickly they release the drug. Regular capsules dissolve in your stomach and are absorbed quickly — usually within 30 minutes to 2 hours — making them us...
- What's the difference between regular ketoprofen capsules and the extended-release capsules?
- Yes, taking it with food, milk, or an antacid is a good idea if your stomach is sensitive — it can help reduce nausea and upset. Food slows down how quickly the drug is absorbed, b...
- This is a really important question to raise with your doctor. Ketoprofen and blood thinners like warfarin can both cause bleeding on their own, and together they significantly rai...
🕸️ Concept Web — How Ketoprofen 50 MG Oral Capsule Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Ketoprofen 50 MG Oral Capsule
RxCUI 197855 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Ketoprofen
6142IN
-
Ketoprofen
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Ketoprofen Oral Capsule
372535SCDF -
Ketoprofen Oral Product
1160961SCDG -
Ketoprofen Pill
1160962SCDG -
Oral Capsule
316965DF -
Oral Product
1151131DFG -
Pill
1151133DFG
-
Ketoprofen Oral Capsule
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Ketoprofen 50 MG
316119SCDC
-
Ketoprofen 50 MG
Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Ketoprofen 50 MG
SCDC · 316119 -
Ketoprofen Oral Capsule
SCDF · 372535 -
Ketoprofen Oral Product
SCDG · 1160961 -
Ketoprofen Pill
SCDG · 1160962
📦 FDA Products & Package NDCs
4 products · 4 package NDCs
4 package NDCs map to RxCUI 197855 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00276-0504-10 | 100 CAPSULE in 1 BOTTLE (0276-0504-10) | Ketoprofen | Misemer Pharmaceuticals, Inc. | 2021-11-01 |
| 00276-0506-10 | 100 CAPSULE in 1 BOTTLE (0276-0506-10) | Ketoprofen | Misemer Pharmaceuticals, Inc. | 2022-09-13 |
| 00276-0507-10 | 100 CAPSULE in 1 BOTTLE (0276-0507-10) | Ketoprofen | Misemer Pharmaceuticals, Inc. | 2025-05-23 |
| 85477-0111-01 | 100 CAPSULE in 1 BOTTLE (85477-111-01) | Ketoprofen | Oncora Pharma, LLC | 2026-03-01 |
Observed labelers:
Misemer Pharmaceuticals, Inc. (3) ·
Oncora Pharma, LLC (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.